Skip to the page

Data / Form D filings / ADvantage Therapeutics, Inc.

ADvantage Therapeutics, Inc.: Form D filings

ADvantage Therapeutics, Inc., a health care company in Miami, FL, filed 4 Form D notices with the SEC between 2021 and 2025. The latest, on July 28, 2025, reports $13.7 million sold of a $25.4 million offering to 24 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
195 NW 40th Street, Miami, FL, 33140
Phone
(630) 886-7345
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1869338

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 28, 2025Amendment$25,449,956$13,737,491$11,712,46524Jun 28, 2023sec.gov
Jul 12, 2023New notice$25,449,956$10,224,998$15,224,95817Jun 28, 2023sec.gov
Jun 15, 2022New notice$7,500,000$275,000$7,225,0003May 31, 2022sec.gov
Jun 24, 2021New notice$10,000,000$5,000,000$5,000,0001Jun 10, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Walter B. SchmidtDirector
Agustin Fernandez Santana IIIExecutive Officer, Director
Jeffrey B. MaddenExecutive Officer, Director
David B. BuchsbaumExecutive Officer
Frank B. MattnerDirector

Other health care companies in Florida that filed recently

Every Form D from the week of Jul 28, 2025 · All recent filings in Florida · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what ADvantage Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.